AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2025
Jan 3, 2025
35599_dirs_2025-01-03_ff6f181b-5cbe-4780-b972-0af34d2ab37b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-12-31
Reporting Person: Andrade Robert (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | Common shares | A | 1042 | — | Acquired | 129465 | Direct |
Footnotes
F1: Represents shares released from restriction from shares awarded 3-31-2023.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20